News & Events

Bone disease webinar

31 March 2021

Bone involvement is one of the most prevalent aspects of GD and a major cause of pain, disability, and reduced quality of life. All three types of Gaucher disease have bone disease in common and can have serious complications in those …

read more »

Become an IGA Volunteer

17 March 2021

We need volunteers to join us and support us in successful achievement of our goals and 2021 work programme.  We have several opportunities open at this moment so please take a look and let us know if you are available to volunteer for us.
…

read more »

February 2021 newsletter

8 March 2021

Sharing our latest newsletter which includes details of our first webinar for 2021, a message of thanks from a young Jordanian patient and the publication of our latest GD booklet to mark Rare Disease Day 2021

You can read the newsletter in full …

read more »

Gaucher disease booklet

22 February 2021

To mark Rare Disease Day 2021, we are pleased to publish our new information booklet on Gaucher disease Types 1, 2 and 3: DOWNLOAD THE BOOKLET HERE

We have developed this booklet as a source of information for patients and their carers and to …

read more »

Wellness for Gaucher disease patients

19 February 2021

As many countries are still in lockdown, people including those living with Gaucher disease are spending a lot of time at home.  The IGA is supporting its members in these difficult times with a webinar: ‘Wellness for …

read more »

PR001 in development by Prevail Therapeutics

4 February 2021

PR001 in development by Prevail Therapeutics

Prevail Therapeutics, a wholly-owned subsidiary of Eli Lilly and Company, is developing an investigational gene therapy called PR001 that has the potential to slow or stop the underlying …

read more »

January 2021 newsletter

19 January 2021

Our first newsletter of 2021 is now available to read, sharing with you the opportunity to get involved in our Gene Therapy focus group and a joint statement with the EWGGD on COVID-19 vaccinations for patients with Gaucher disease.

Gene Therapy Focus Group

14 January 2021

The IGA is looking for Gaucher patients and parent/caregivers to join a focus group to discuss gene therapy. We are seeking to understand the concerns and questions the community has around this potential new treatment. The focus group will last for …

read more »

Vaccination program for COVID-19 in patients with Gaucher disease

14 January 2021

The EWGGD and IGA are standing together with the Gaucher patients’ community in this challenging time of the COVID-19 pandemic, and we are strongly supportive of the vaccination program for COVID-19 and hopes that any patient who is offered …

read more »

A Charitable Access Program for patients with lysosomal storage disorders in underserved communities worldwide

8 January 2021

A paper on a Charitable Access Program for patients with lysosomal storage disorders in underserved communities worldwide has now been published online on the Orphanet Journal of Rare Diseases (OJRD) website.

IGA's CEO, Tanya Collin-Histed …

read more »